
Production incidents in pharma aren’t rare but the scale at which they persist is the real concern.
In many plants, 50–100 incidents remain open at any time, some for over 90 days. The impact? Delayed batch releases, stretched QA teams, management bandwidth getting consumed, and a slow but steady erosion of compliance and efficiency.
And this continues despite structured systems like doer-checker being in place.
This article by Vivek Karan, explains how:
• operators and supervisors are stuck in reinforcing loops of inefficiency
• human errors (making up 50%–60% of incidents) driven by multitasking and cognitive overload
It also outlines a practical, GMP-aligned approach to move from constant firefighting to stable, high-performance operations that will reduce incidents and speed up closures.
Visit our website to read the full article: From errors to excellence. A GMP-aligned approach to reducing incidents.

English



























